Johnson & Johnson JNJ
NYSE JNJ
$266.34 -0.74 (-0.28%)
As of: Sep 10, 2026 · 3:59 PM EDT

Johnson & Johnson (JNJ) Exchange Rate Effect (2009 - 2026)

Johnson & Johnson's (JNJ) quarterly Exchange Rate Effect came in at $5.0 million in Q2 2026, down 96.75% year-over-year from $154.0 million in Q2 2025, and up 120.0% quarter-over-quarter from -$25.0 million in Q1 2026.

Analysis

Johnson & Johnson (JNJ) Exchange Rate Effect (2009 - 2026) Analysis & Trends

Johnson & Johnson has disclosed Exchange Rate Effect across 18 years of filings, most recently posting $5.0 million for Q2 2026.

  • In Q2 2026, Exchange Rate Effect fell 96.75% year-over-year to $5.0 million; the TTM figure through Jun 2026 stood at -$43.0 million (down 129.66% YoY), while the FY2025 annual figure was $201.0 million, up 169.55% from the prior year.
  • Exchange Rate Effect came in at $5.0 million for Q2 2026 at Johnson & Johnson, up from -$25.0 million in the prior quarter.
  • In the past five years, Exchange Rate Effect ranged from a high of $154.0 million in Q2 2025 to a low of -$198.0 million in Q4 2024.
  • Average Exchange Rate Effect over 5 years is -$24.4 million, with a median of -$10.0 million recorded in 2026.
  • Year-over-year, Exchange Rate Effect plunged 546.43% in 2024 and surged 281.18% in 2025.
  • Over 5 years, Exchange Rate Effect stood at $16.0 million in 2022, then jumped by 681.25% to $125.0 million in 2023, then plunged by 258.4% to -$198.0 million in 2024, then jumped by 111.62% to $23.0 million in 2025, then tumbled by 78.26% to $5.0 million in 2026.
  • Per Business Quant data, the three most recent Exchange Rate Effect figures were $5.0 million in Q2 2026, -$25.0 million in Q1 2026, and $23.0 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Exchange Rate Effect (Qtr)
1 Johnson & Johnson 641.14 Bn 620.38 Bn 17.26 Bn 5.00 Mn
2 AbbVie 451.04 Bn 444.47 Bn 12.70 Bn -7.00 Mn
3 Merck 357.43 Bn 350.29 Bn 12.21 Bn -37.00 Mn
4 Novartis Ag 266.73 Bn 259.04 Bn 11.24 Bn -18.00 Mn
5 Pfizer 157.52 Bn 145.82 Bn 10.94 Bn -4.00 Mn
6 Sanofi 52.14 Bn 44.76 Bn 10.79 Bn 11.62 Mn
7 Revolution Medicines 42.88 Bn 42.88 Bn - -
8 Incyte 24.70 Bn 20.16 Bn 1.57 Bn -84,000.00
9 United Therapeutics 21.47 Bn 18.80 Bn 683.80 Mn -
10 Neurocrine Biosciences 15.82 Bn 15.43 Bn 935.80 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 28, 2026 5.00 Mn
Mar 29, 2026 -25.00 Mn
Dec 28, 2025 23.00 Mn
Sep 28, 2025 -46.00 Mn
Jun 29, 2025 154.00 Mn
Mar 30, 2025 70.00 Mn
Dec 29, 2024 -198.00 Mn
Sep 29, 2024 119.00 Mn
Jun 30, 2024 -85.00 Mn
Mar 31, 2024 -125.00 Mn
Dec 31, 2023 125.00 Mn
Oct 1, 2023 -168.00 Mn
Jul 2, 2023 -97.00 Mn
Apr 2, 2023 28.00 Mn
Jan 1, 2023 -187.00 Mn
Apr 3, 2022 16.00 Mn
Oct 3, 2021 -92.00 Mn
Jul 4, 2021 45.00 Mn
Apr 4, 2021 -78.00 Mn
Jan 3, 2021 224.00 Mn